These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 12453746)

  • 1. The brain tells: early signs of depression recovery.
    Harv Ment Health Lett; 2002 Nov; 19(5):6. PubMed ID: 12453746
    [No Abstract]   [Full Text] [Related]  

  • 2. The review by Weinmann and colleagues.
    Freemantle N
    Psychopharmacology (Berl); 2008 Jul; 199(1):131-2; author reply 133-4. PubMed ID: 18504557
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression.
    Hunter AM; Leuchter AF; Morgan ML; Cook IA
    Am J Psychiatry; 2006 Aug; 163(8):1426-32. PubMed ID: 16877657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo.
    Entsuah AR; Huang H; Thase ME
    J Clin Psychiatry; 2001 Nov; 62(11):869-77. PubMed ID: 11775046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo.
    Shelton C; Entsuah R; Padmanabhan SK; Vinall PE
    Int Clin Psychopharmacol; 2005 Jul; 20(4):233-8. PubMed ID: 15933485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression.
    Schatzberg A; Roose S
    Am J Geriatr Psychiatry; 2006 Apr; 14(4):361-70. PubMed ID: 16582045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regarding "Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs".
    Koesters M; Becker T; Weinmann S
    Biol Psychiatry; 2009 Sep; 66(5):e7; authour reply e9-10. PubMed ID: 19520365
    [No Abstract]   [Full Text] [Related]  

  • 8. Three new antidepressants.
    Drug Ther Bull; 1996 Sep; 34(9):65-8. PubMed ID: 8885497
    [No Abstract]   [Full Text] [Related]  

  • 9. Venlafaxine and nefazodone, two pharmacologically distinct antidepressants.
    Augustin BG; Cold JA; Jann MW
    Pharmacotherapy; 1997; 17(3):511-30. PubMed ID: 9165554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: a meta-analysis of randomized controlled trials.
    Einarson TR; Arikian SR; Casciano J; Doyle JJ
    Clin Ther; 1999 Feb; 21(2):296-308. PubMed ID: 10211533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinically relevant pharmacokinetic interaction between venlafaxine and bupropion: a case series.
    Paslakis G; Gilles M; Deuschle M
    J Clin Psychopharmacol; 2010 Aug; 30(4):473-4. PubMed ID: 20631572
    [No Abstract]   [Full Text] [Related]  

  • 12. Saving lives: can we predict and prevent adolescent suicide?
    Weder N
    J Am Acad Child Adolesc Psychiatry; 2012 Apr; 51(4):339-40. PubMed ID: 22449635
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH; Andersen HF; Lam RW
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A place for SSRIs in the treatment of severely depressed children and adolescents].
    Roobol TH; Buitelaar JK
    Ned Tijdschr Geneeskd; 2008 Aug; 152(31):1710-2. PubMed ID: 18727599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual action antidepressants and some important considerations.
    Gupta RK; Tiller JW; Burrows GD
    Aust N Z J Psychiatry; 2003 Apr; 37(2):190-5. PubMed ID: 12656958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Joy returns last: anhedonia and treatment resistance in depressed adolescents.
    Rubin DH
    J Am Acad Child Adolesc Psychiatry; 2012 Apr; 51(4):353-5. PubMed ID: 22449641
    [No Abstract]   [Full Text] [Related]  

  • 17. The treatment of major depressive disorders (MDD) in Thailand using escitalopram compared to fluoxetine and venlafaxine: a pharmacoeconomic evaluation.
    Kongsakon R; Bunchapattanasakda C
    J Med Assoc Thai; 2008 Jul; 91(7):1117-28. PubMed ID: 18839855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venlafaxine.
    Ereshefsky L
    Am Fam Physician; 1997 Nov; 56(8):1964, 1967, 1970. PubMed ID: 9390093
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.
    Bauer M; Tharmanathan P; Volz HP; Moeller HJ; Freemantle N
    Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):172-85. PubMed ID: 19165525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of venlafaxine versus specific serotonin reuptake inhibitors in treatment of major depressive disorder: a meta-analysis of published studies.
    de Silva VA; Hanwella R
    Int Clin Psychopharmacol; 2012 Jan; 27(1):8-16. PubMed ID: 21971532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.